{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-008734","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.194170+00:00","generated_at":"2026-06-01T07:44:26.630767+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Harmony Biosciences shareholders elect all three Class I directors and ratify Deloitte as auditor","bullets":["Jeffrey S. Aronin, R. Mark Graf, and Jeffrey M. Dayno elected as Class I directors with votes ranging from 18.3M to 20.6M for.","Ratification of Deloitte & Touche LLP as independent auditor for 2024 passed with 40.2M votes for, 495k against, 12,722 abstain.","Approximately 40.7M shares (quorum) represented at the 2024 Annual Meeting held May 29, 2024.","All director nominees will serve until the 2027 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-008734","json":"https://secwatch.observer/filing/0001558370-24-008734.json","markdown":"https://secwatch.observer/filing/0001558370-24-008734.md","text":"https://secwatch.observer/filing/0001558370-24-008734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/0001558370-24-008734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/hrmy-20240529x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:44:26.630767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}